Rehmann Capital Advisory Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Rehmann Capital Advisory Group’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$15.3K	Hold	124	–	–	﹤0.01%	935
2019 Q2	$17.5K	Hold	124	–	–	﹤0.01%	1181
2019 Q1	$18.7K	Buy	+124	New	+$17.8K	﹤0.01%	1139
2018 Q4	–	Sell	-130	Closed	-$20.6K	–	1910
2018 Q3	$20.6K	Buy	130 +6	+5%	+$908	﹤0.01%	1106
2018 Q2	$17.4K	Hold	124	–	–	﹤0.01%	1157
2018 Q1	$16K	Buy	+124	New	+$16.9K	﹤0.01%	1145

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Rehmann Capital Advisory Group's FBT Position: Q3 2019 in Review

Rehmann Capital Advisory Group held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q3 2019 at 124 shares worth $15.3K. The position accounts for ﹤0.01% of the portfolio, ranked #935.

Rehmann Capital Advisory Group first reported a position in FBT in Q1 2018 and has held it in 6 quarters since. The position peaked at $20.6K in Q3 2018. 188 funds tracked by Wall St. Rank hold FBT as of Q3 2019.

Rehmann Capital Advisory Group held 124 shares of First Trust NYSE Arca Biotechnology Index Fund worth $15.3K as of Q3 2019.
Rehmann Capital Advisory Group left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q3 2019.
First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Rehmann Capital Advisory Group's portfolio in Q3 2019, its #935 holding.
Rehmann Capital Advisory Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2018 and has held it in 6 quarters since.
Rehmann Capital Advisory Group's First Trust NYSE Arca Biotechnology Index Fund position peaked at $20.6K in Q3 2018.
188 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2019, filed 2 Jan 2020.